Open Access · CC BY 4.0
Correction to “Asprosin Protects H9C2 Cells From Ferroptosis Following Hypoxia/Reoxygenation by Promoting Mitophagy”
Cardiovascular Therapeutics · 2026-01 · 2026 (1)
DOI: 10.1155/cdr/9810149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Therapeutics, online erschienen am 13.07.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Correction to “Asprosin Protects H9C2 Cells From Ferroptosis Following Hypoxia/Reoxygenation by Promoting Mitophagy”. Cardiovascular Therapeutics, 2026(1). https://doi.org/10.1155/cdr/9810149
Vancouver
Correction to “Asprosin Protects H9C2 Cells From Ferroptosis Following Hypoxia/Reoxygenation by Promoting Mitophagy”. Cardiovascular Therapeutics. 2026;2026(1). doi:10.1155/cdr/9810149
BibTeX
@article{euvimed2026,
title = {Correction to “Asprosin Protects H9C2 Cells From Ferroptosis Following Hypoxia/Reoxygenation by Promoting Mitophagy”},
journal = {Cardiovascular Therapeutics},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/cdr/9810149}
}
EUVIMED